Johnson & Johnson and AstraZeneca will get a chance to exit the orphan disease therapy developer, which has filed for an $86.3m IPO.

Principia Biopharma, whose drug discovery platform is based on research at UCSF, has completed a $122m initial public offering after underwriters exercised their greenshoe option.

The Novo-backed medical implant provider has filed to raise up to $97.8m in an initial public offering that comes after $103m in funding.

Karolinska Development has celebrated an exit as Umeå spinout Asarina Pharma went public in Sweden after raising $16.3m in its initial public offering.

Salesforce Ventures will exit cloud communications software provider NewVoiceMedia, which had raised more than $140m in venture funding.

Expense management platform Captio has been acquired by Certify for an undisclosed sum, providing exits to Bankinter and Banco Sabadell.

Canopy Rivers, the corporate venturing unit spun out of cannabis grower Canopy Growth, has gone public through a reverse merger.

Zalando and Children’s Investment Fund Foundation have added $2.5m to Working Capital's supply chain-focused fund, which now stands at $25.2m.

Technion’s robotic surgery business Mazor Robotics has been snapped up by medical device developer Medtronic, which had already invested $72m in the company.

The Rocket Internet-backed e-commerce platform is considering an initial public offering in the US early next year at a valuation of $1bn.